Unveiling immune targets via TriStageHLA: high-throughput screening of peptide presentation, peptide-HLA binding, and immunogenicity
High-throughput screening of HLA class I epitopes underpins neoantigen vaccine design, T cell therapies, and pathogen immune monitoring, yet proteome-scale